Rare diseases
Investigational molecules
Locations
10880 Wilshire Boulevard Suite 2150, 90024-4106, United States
Puma Biotechnology Inc. focuses on clinical research in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) recurrent or metastatic breast cancer, with interest in treatment settings where disease has returned or spread.
The sponsor’s research activity is centered on therapies used alongside endocrine therapy in advanced breast cancer care.
Puma Biotechnology Inc. runs clinical trials in conditions such as Small cell lung cancer, Hormone receptor positive HER2 negative breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
PortugalIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
